LOMBARD MED INC - COM (EVAR)

CUSIP: G55598109

Q2 2016 13F Holders as of 30 Jun 2016

Type / Class
Equity / COM
Total 13F shares
11,990,067
Share change
-227,289
Total reported value
$13,068,000
Price per share
$1.09
Number of holders
12
Value change
-$242,142
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP G55598109?
CUSIP G55598109 identifies EVAR - LOMBARD MED INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LOMBARD MED INC - COM (EVAR) as of Q2 2016

As of 30 Jun 2016, LOMBARD MED INC - COM (EVAR) was held by 12 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,990,067 shares. The largest 10 holders included Invesco Ltd., Abingworth LLP, SV Life Sciences Advisers, LLC, Aisling Capital LLC, DEUTSCHE BANK AG\, CITADEL ADVISORS LLC, Texas Yale Capital Corp., GOLDMAN SACHS GROUP INC, Verition Fund Management LLC, and BlackRock Fund Advisors. This page lists 12 institutional shareholders reporting positions in this security for the Q2 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.